United Kingdom: Life Sciences, Biotechnology & Nanotechnology

As humanity ventures beyond Earth, the challenge of sustaining life in space demands revolutionary approaches to food production. From radiation-resistant seed coatings to microgravity-adapted root systems, innovations in space agriculture are creating new frontiers for patent protection while simultaneously offering solutions to terrestrial farming challenges.

Technology aimed at improving independence following spinal cord injury continues to develop, from mobility equipment already on the market to implantable devices that are still at an early stage of research. This article examines three different technologies and considers how developments such as these could shape the lives of people living with SCI, as well as what they might mean for future claims.

Nomio, a broccoli-based sports supplement gaining popularity among endurance athletes, has secured patent protection for its innovative use of sulforaphane to enhance exercise performance and treat metabolic conditions. This analysis explores how the company leveraged university research to protect both therapeutic and non-therapeutic applications of their simple three-ingredient formula, demonstrating that even products with common ingredients can achieve robust patent protection through novel use claims.

Marc Dautlich and Alex Denoon explore the complexities of the EU AI Act's Declaration of Conformity requirements, specifically examining what it means for High-Risk AI Systems to comply with GDPR. The podcast addresses the practical challenges providers face when preparing this living document for AI-integrated medical devices and other regulated systems.

Eversheds Sutherland provides legal insights and analysis through their Global Life Sciences and Healthcare Bulletin series. The firm's international team of attorneys offers guidance on regulatory developments, compliance matters, and strategic considerations affecting pharmaceutical, biotechnology, and healthcare organizations. Contact their specialized practitioners for detailed counsel on navigating complex legal frameworks in the life sciences sector.

The regulation of non-surgical aesthetics in England is approaching an important turning point. Although there is not yet a comprehensive statutory licensing regime, aesthetics businesses and regulated healthcare professionals already operate within a complex framework of professional, medicines, and product regulation. Further regulation is also being developed specifically for non-surgical cosmetic procedures.

European patent filing data reveals dramatic growth in three chemistry sectors over the past decade, with materials and metallurgy filings surging nearly 40%, surface technology and coatings rising 35%...

European regulators are accelerating AI governance frameworks while balancing innovation with patient safety in digital health. The European Commission has published voluntary codes for AI-generated content marking and appointed expert bodies to enforce the AI Act, while the UK's MHRA launches regulatory sandboxes to test AI tools in medicines development and the ICO establishes comprehensive guidance for AI-powered healthcare technologies.

The World has changed; we can be certain that in an age where generative AI has become readily available to scientists, engineers and creatives, the prospects for potential leaps in innovation seem boundless.